Drug Class
PD-L1 inhibitor
Type
ingredient
Active Ingredient
durvalumab
📋Overview
Durvalumab is a type of immunotherapy drug known as a monoclonal antibody. It works by targeting and blocking a protein called PD-L1, which can help the immune system recognize and attack cancer cells. Durvalumab is commonly associated with the treatment of certain cancers, including lung cancer and bladder cancer. Its use is part of a broader approach to harness the body's immune response against malignancies.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Durvalumab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.